BioCardia BCDA reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
BioCardia beat estimated earnings by 44.0%, reporting an EPS of $-0.14 versus an estimate of $-0.25.
Revenue was up $905 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.05 which was followed by a 11.86% increase in the share price the next day.
Here's a look at BioCardia's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.24 | -0.21 | -0.21 | -0.2 |
| EPS Actual | -0.19 | -0.21 | -0.16 | -0.2 |
| Revenue Estimate | 130K | 40K | 10K | 20K |
| Revenue Actual | 60K | 79K | 821K | 69K |
To track all earnings releases for BioCardia visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: EarningsBZI-Recaps